Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5729725 | European Urology Focus | 2016 | 7 Pages |
Abstract
Castration-resistant prostate cancer is characterized by multiple resistance mechanisms to androgen deprivation treatment and remains an incurable disease. An understanding of the mechanisms underlying this resistance is necessary to identify future therapeutic targets.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Derya Tilki, Edward M. Schaeffer, Christopher P. Evans,